|
HEATR2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.05620023416986E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.9768000014686E-08 |
| Normal-vs-Stage2 |
1.981580E-02 |
| Normal-vs-Stage3 |
3.798300E-04 |
| Normal-vs-Stage4 |
4.41540000000185E-05 |
| Stage1-vs-Stage2 |
2.784400E-01 |
| Stage1-vs-Stage3 |
4.819200E-01 |
| Stage1-vs-Stage4 |
3.943200E-01 |
| Stage2-vs-Stage3 |
6.216600E-01 |
| Stage2-vs-Stage4 |
1.435810E-01 |
| Stage3-vs-Stage4 |
2.193600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.06899999752619E-09 |
| Normal-vs-AfricanAmerican |
9.421700E-03 |
| Normal-vs-Asian |
5.464000E-02 |
| Caucasian-vs-AfricanAmerican |
7.698000E-01 |
| Caucasian-vs-Asian |
1.731230E-01 |
| AfricanAmerican-vs-Asian |
3.829700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.81350000150982E-08 |
| Normal-vs-Female |
7.4823999995921E-08 |
| Male-vs-Female |
2.758600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.984100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.20989999996546E-06 |
| Normal-vs-Age(61-80Yrs) |
5.7869999903204E-09 |
| Normal-vs-Age(81-100Yrs) |
4.337400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.629800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.597200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.606400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.717800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.666000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.315000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.861800E-02 |
| Normal-vs-Grade 2 |
1.48220000051325E-07 |
| Normal-vs-Grade 3 |
3.15530000016828E-07 |
| Normal-vs-Grade 4 |
8.186700E-04 |
| Grade 1-vs-Grade 2 |
4.641600E-01 |
| Grade 1-vs-Grade 3 |
4.838000E-01 |
| Grade 1-vs-Grade 4 |
6.453600E-01 |
| Grade 2-vs-Grade 3 |
9.585600E-01 |
| Grade 2-vs-Grade 4 |
7.361800E-01 |
| Grade 3-vs-Grade 4 |
7.701800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72769998307842E-09 |
| Normal-vs-ccB subtype |
2.221900E-04 |
| ccA subtype-vs-ccB subtype |
2.784200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.25839999981703E-07 |
| Normal-vs-N1 |
1.059550E-02 |
| N0-vs-N1 |
9.510400E-02 |
|
|
